-

Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that on February 6, 2023 the Compensation Committee of Oscar’s Board of Directors approved the grant of inducement restricted stock unit awards covering 832,126 Class A shares of Oscar’s common stock to 12 new non-executive employees of Oscar and its affiliates to induce them to join Oscar and its affiliates. The awards were granted under Oscar’s 2022 Employment Inducement Award Plan, and generally vest quarterly over either a one-year period or a three-year period following their grant, subject to continued employment. The awards were granted as employment inducement awards pursuant to the New York Stock Exchange rules.

About Oscar Health
Oscar Health, Inc. is the first health insurance company built around a full stack technology platform and a relentless focus on serving its members. At Oscar, our mission is to make a healthier life accessible and affordable for all. Headquartered in New York City, Oscar has been challenging the healthcare system’s status quo since our founding in 2012. The Company’s member-first philosophy and innovative approach to care has earned us the trust of over one million members as of December 31, 2022. We offer Individual & Family, Small Group and Medicare Advantage plans, and +Oscar, our full stack technology platform to others. Our vision is to refactor healthcare to make good care cost less. Refactor is a term used in software engineering that means to improve the design, structure, and implementation of the software, while preserving its functionality. At Oscar, we take this definition a step further. We improve our members’ experience by building trust through deep engagement, personalized guidance, and rapid iteration.

For more information, please visit www.hioscar.com.

Contacts

IR:
Cornelia Miller, Oscar
917-397-0251
cornelia@hioscar.com

MEDIA:
Jackie Kahn, Oscar
202-538-0128
jkahn@hioscar.com

Oscar Health, Inc.

NYSE:OSCR

Release Versions

Contacts

IR:
Cornelia Miller, Oscar
917-397-0251
cornelia@hioscar.com

MEDIA:
Jackie Kahn, Oscar
202-538-0128
jkahn@hioscar.com

More News From Oscar Health, Inc.

Oscar Health, Inc. 2025 First Quarter Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar’s investor relations we...

Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2024. “Oscar reported positive full year 2024 results, capping the strongest year of financial performance in Company history,” said Mark Bertolini, CEO of Oscar Health. “We reported both Adjusted EBITDA and net income profitability – two significant milestones. Our strong top...

Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar’s inv...
Back to Newsroom